Larimar Beats Q2 Loss Estimates
Larimar Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.51
+6.0% in 1d after detection
Post-detection moves
1h
—
1d
+6.0%
3d
+3.6%
7d
+4.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS